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24
Toxoplasmic encephalitis is an AIDS-defining condition in HIV + individuals. and this increased survival is dependent on both IL-12-and IL-18-driven IFN-γ production.
33
Processing and secretion of IFN-γ-inducing, bioactive IL-18 is dependent on the sensing of mirroring the results seen 5 days after a cyst inoculation (Fig 1B) . Importantly, at 24 hours after 145 tachyzoite inoculation, levels of other acute inflammatory mediators, such as IL-6, TNFα and 146 IL-10, were almost indistinguishable from naïve mice (Fig 1E-G hours after inoculation, the levels of IL-18 mirrored those of IFN-γ for up to 72 hours (Fig 2B) .
174
Furthermore, treatment with anti-IL-12 and/or anti-IL-18 also reduced concentrations of IFN-175 γ, IL-12 and IL-18 in the serum of infected mice in an additive manner (Fig 2D-F parasites induced IFN-γ secretion and increased serum IL-18 levels (Fig 5A, B) . (Fig 5C, D) . At 48 hours after 262 tachyzoite inoculation, the levels of serum IL-18 were even significantly higher compared with 263 inoculation of T. gondii ME49 (Fig 5D) . accompanied by a weight loss from which mice recovered within a few days (data not shown).
299
Forty-eight hours after the last IL2C treatment, mice were inoculated orally with 10 or 40 T.
300
gondii ME49 cysts and were assessed for weight loss and survival over 60 days. All mice that 301 had been inoculated with 40 cysts and 87% of mice that had been inoculated with 10 cysts, but
302
had not received IL2C injections, succumbed within 14 days after inoculation (Fig 7B, C) To assess if IL2C pre-treatment also impacts on measurable disease parameters other than 323 survival, we also analyzed parasite burden and immunopathology at 2, 4 and 9 days following 324 oral cyst infection. Due to the low infectious dose of 10 cysts, only minimal changes in 325 immunopathology were observed at 2 and 4 days after infection in all groups (data not shown).
326
At 9 days after infection, IL2C pre-treated mice displayed significantly reduced gross pathology 327 of gut and liver (Fig 7G, H Ex vivo IFN-γ secretion by distinct lymphocyte subsets was assessed as described previously 
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